Your browser doesn't support javascript.
loading
ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function.
Baron, Desiree M; Fenton, Adam R; Saez-Atienzar, Sara; Giampetruzzi, Anthony; Sreeram, Aparna; Keagle, Pamela J; Doocy, Victoria R; Smith, Nathan J; Danielson, Eric W; Andresano, Megan; McCormack, Mary C; Garcia, Jaqueline; Bercier, Valérie; Van Den Bosch, Ludo; Brent, Jonathan R; Fallini, Claudia; Traynor, Bryan J; Holzbaur, Erika L F; Landers, John E.
Afiliação
  • Baron DM; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Fenton AR; Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Pennsylvania Muscle Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Saez-Atienzar S; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD 20892, USA.
  • Giampetruzzi A; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Sreeram A; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Shankaracharya; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Keagle PJ; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Doocy VR; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Smith NJ; Department of Biochemistry, University of Nebraska-Lincoln, Lincoln, NE 68588, USA.
  • Danielson EW; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Andresano M; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • McCormack MC; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Garcia J; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Bercier V; KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven, Belgium; VIB, Center for Brain & Disease Research, Laboratory of Neurobiology, Leuven, Belgium.
  • Van Den Bosch L; KU Leuven-University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), Leuven, Belgium; VIB, Center for Brain & Disease Research, Laboratory of Neurobiology, Leuven, Belgium.
  • Brent JR; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
  • Fallini C; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA; George and Anne Ryan Institute for Neuroscience, University of Rhode Island, Kingston, RI 02881, USA; Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881, USA; Departme
  • Traynor BJ; Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD 20892, USA; Department of Neurology, Johns Hopkins University, Baltimore, MD 21287, USA; Therapeutic Development Branch, National Center for Advancing Translational Sciences, NIH, Roc
  • Holzbaur ELF; Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA; Pennsylvania Muscle Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
  • Landers JE; Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01605, USA. Electronic address: john.landers@umassmed.edu.
Cell Rep ; 39(1): 110598, 2022 04 05.
Article em En | MEDLINE | ID: mdl-35385738
ABSTRACT
Understanding the pathogenic mechanisms of disease mutations is critical to advancing treatments. ALS-associated mutations in the gene encoding the microtubule motor KIF5A result in skipping of exon 27 (KIF5AΔExon27) and the encoding of a protein with a novel 39 amino acid residue C-terminal sequence. Here, we report that expression of ALS-linked mutant KIF5A results in dysregulated motor activity, cellular mislocalization, altered axonal transport, and decreased neuronal survival. Single-molecule analysis revealed that the altered C terminus of mutant KIF5A results in a constitutively active state. Furthermore, mutant KIF5A possesses altered protein and RNA interactions and its expression results in altered gene expression/splicing. Taken together, our data support the hypothesis that causative ALS mutations result in a toxic gain of function in the intracellular motor KIF5A that disrupts intracellular trafficking and neuronal homeostasis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Lateral Amiotrófica Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Lateral Amiotrófica Idioma: En Ano de publicação: 2022 Tipo de documento: Article